B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 9.55 USD -2.85% Market Closed
Market Cap: 775m USD
Have any thoughts about
Bioventus Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one BVS stock under the Base Case scenario is 13.12 USD. Compared to the current market price of 9.55 USD, Bioventus Inc is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BVS Relative Value
Base Case
13.12 USD
Undervaluation 27%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
36
vs Industry
70
Median 3Y
1
Median 5Y
1.2
Industry
2.3
Forward
1.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-1.3
Industry
23
Forward
23.2
More Details
26
P/OCF
P/OCF
Price to OCF
26
vs History
36
vs Industry
4
Median 3Y
28.5
Median 5Y
27.1
Industry
14.3
More Details
43.7
P/FCFE
P/FCFE
Price to FCFE
43.7
vs History
14
vs Industry
Median 3Y
4.8
Median 5Y
3.4
Industry
20
More Details
5.2
P/B
P/B
Price to Book Value
5.2
vs History
10
vs Industry
33
Median 3Y
1.9
Median 5Y
2.2
Industry
2.2
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
36
vs Industry
58
Median 3Y
1.6
Median 5Y
1.8
Industry
2.4
Forward
1.9
More Details
2.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.9
vs History
31
vs Industry
66
Median 3Y
2.5
Median 5Y
2.7
Industry
5
More Details
16.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.4
vs History
36
vs Industry
31
Median 3Y
17.7
Median 5Y
16.6
Industry
12.9
Forward
10.1
More Details
66.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
66.4
vs History
12
vs Industry
9
Median 3Y
-9.2
Median 5Y
25.1
Industry
17.4
Forward
11.3
More Details
36.1
EV/OCF
EV/OCF
Enterprise Value to OCF
36.1
vs History
55
vs Industry
2
Median 3Y
47
Median 5Y
43.5
Industry
14
More Details
37.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
37.1
vs History
44
vs Industry
1
Median 3Y
48.3
Median 5Y
34.4
Industry
18.2
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
19
vs Industry
57
Median 3Y
0.9
Median 5Y
1
Industry
1.9
More Details

Multiples Across Competitors

BVS Competitors Multiples
Bioventus Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bioventus Inc
NASDAQ:BVS
774.7m USD 1.4 -19.6 16.4 66.4
JP
Hoya Corp
TSE:7741
7T JPY 8.6 35.9 23.7 28.5
CH
Alcon AG
SIX:ALC
38.2B CHF 4.3 36.2 17.8 34.4
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.1 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 36.8 18.6 22.4
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 198.6 -55.5 -85.5 -80.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51B CNY 11.5 27.6 23.9 23.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.7B USD 4.5 15.8 10.9 12.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.3 -17.1 16.6 55.6
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.1 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.5 23.2 38.1
P/E Multiple
Earnings Growth PEG
US
B
Bioventus Inc
NASDAQ:BVS
Average P/E: 33.9
Negative Multiple: -19.6 		N/A N/A
JP
Hoya Corp
TSE:7741
35.9
15%
2.4
CH
Alcon AG
SIX:ALC
36.2
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.1
15%
2.3
US
Align Technology Inc
NASDAQ:ALGN
36.8
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.8
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.1 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.1
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.5
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
B
Bioventus Inc
NASDAQ:BVS
Average EV/EBITDA: 43.8
16.4
30%
0.5
JP
Hoya Corp
TSE:7741
23.7
15%
1.6
CH
Alcon AG
SIX:ALC
17.8
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.6
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.6
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.9
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.9
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.6
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.5
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1

See Also

Summary
BVS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BVS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BVS stock valuation using valuation multiples.
Wall Street Estimates
BVS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BVS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.